San Francisco
Dr. David Anschütz
Principal Associate
San Francisco: +1 415 400 2200
Frankfurt am Main: +49 69 27 30 80
About
David is a principal associate in our corporate/M&A team and member of our global transactions group.
He has broad experience advising financial sponsors and corporations on domestic and cross-border M&A transactions across a range of industries.
David is currently based in the firm's San Francisco and Frankfurt offices.
He is fluent in German and English.
Additional Information
- Arteris on its acquisition of Cycuity
- Merck KGaA on the acquisition of the chromatography business of JSR Life Sciences
- Klocke Group and IDT Biologika on strategic partnership with SK bioscience
- One Equity Partners on the sale of Walki to Oji Holdings Corporation
- One Equity Partners on the acquisition of Fortaco group from CapMan Buyout
- International Chemical Investors Group on the sale of Corden Pharma to Astorg
- Corden Pharma on the acquisition of three production sites from Vifor Pharma
- Lindsay Goldberg on the sale of PACCOR group to Faerch group
- One Equity Partners on the sale of Lutech to Apax
- One Equity Partners on the acquisition of a 29% stake in Cicor Technologies AG from HEB Swiss Investment AG
Dr. David Anschütz
Principal Associate
San Francisco Office
One Bush Street
17th Floor
94104 San Francisco
Frankfurt am Main Office
Große Gallusstraße 14
60315 Frankfurt am Main